ERBB2 and breast carcinoma: The large sample size of the METABRIC analysis also revealed Annexin A2 to be upregulated in HER2 positive breast cancer, contradicting what has been previously published [44] and suggesting the value of investigating Annexin A2 in breast cancer is not limited to the triple negative subtypes.